Related Experiment Video
Updated: May 24, 2025

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
PA1b-like peptides alleviate mitochondrial dysfunction induced by glucose toxicity through interaction with VDAC1 in
Huizhong Huang1, Xinyu Zeng1, Liying Zhang1
1Sino-German Biomedical Center, Hubei Provincial Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, 430068 Wuhan, Hubei, China. yaochenguang@hbut.edu.cn.
Abstract:
PA1b-like peptides, which are extracted from the seeds of members of the Fabaceae family, display remarkable hypoglycemic and β-cell-protective activities when administered orally. However, the direct targets and mechanisms of action of these peptides in islet β-cells remain unclear. In this study, we found that PA1b-like peptides were mainly distributed in the cotyledon of soybean, rather than in the germ and seed coat. We also identified a direct interaction between PA1b-like peptides and voltage-dependent anion channels (VDACs), with binding energies less than -7 kcal mol-1. Molecular dynamics simulations demonstrated that hydrogen bonding, hydrophobic interactions, and van der Waals forces assist these peptides in forming stable and tight complexes with VDAC1. Moreover, as a member of the PA1B-like peptide family, vglycin (VG) protected mitochondrial function by maintaining the ROS level, ATP production, mitochondrial membrane potential (ΔΨm), intracellular Ca2+ inflow and insulin secretion in β-cells under high glucose stimulation. All these effects were reliant on the direct interaction between VG and VDAC1 in β-cells. This study provides a new strategy for the restoration of mitochondrial function in β-cells under glucose toxicity and establishes a theoretical basis for the treatment of type 2 diabetes (T2D) by PA1b-like peptides.
Related Concept Videos
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

